Functional network alterations differently associated with suicidal ideas and acts in depressed patients: an indirect support to the transition model.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
04 02 2021
Historique:
received: 09 06 2020
accepted: 18 01 2021
revised: 08 01 2021
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 29 6 2021
Statut: epublish

Résumé

The transition from suicidal ideas to a suicide act is an important topic of research for the identification of those patients at risk of acting out. We investigated here whether specific brain activity and connectivity measures at rest may be differently associated with suicidal thoughts and behaviors. A large sample of acutely depressed patients with major depressive disorder was recruited in three different centers (Montreal/Canada, Stanford/USA, and Jena/Germany), covering four different phenotypes: patients with a past history of suicide attempt (n = 53), patients with current suicidal ideas but no past history of suicide attempt (n = 40), patients without current suicidal ideation nor past suicide attempts (n = 42), and healthy comparison subjects (n = 107). 3-T resting-state functional magnetic resonance imaging (fMRI) measures of the amplitude of low-frequency fluctuation (ALFF) and degree centrality (DC) were obtained and examined in a whole-brain data-driven analysis. Past suicide attempt was associated with a double cortico-subcortical dissociation in ALFF values. Decreased ALFF and DC values mainly in a frontoparietal network and increased ALFF values in some subcortical regions (hippocampus and thalamus) distinguished suicide attempters from suicide ideators, patient controls, and healthy controls. No clear neural differences were identified in relation to suicidal ideas. Suicide attempters appear to be a distinct subgroup of patients with widespread brain alterations in functional activity and connectivity that could represent factors of vulnerability. Our results also indirectly support at the neurobiological level the relevance of the transition model described at the psychological and clinical levels. The brain bases of suicidal ideas occurrence in depressed individuals needs further investigations.

Identifiants

pubmed: 33542184
doi: 10.1038/s41398-021-01232-x
pii: 10.1038/s41398-021-01232-x
pmc: PMC7862288
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100

Subventions

Organisme : American Foundation for Suicide Prevention (AFSP)
ID : SRG-0- 10-302

Références

Clin Psychol Rev. 2015 Aug;40:170-83
pubmed: 26135816
Neuroimage. 2009 Feb 1;44(3):893-905
pubmed: 18976716
Trends Cogn Sci. 2011 Oct;15(10):453-9
pubmed: 21889391
J Consult Clin Psychol. 2020 Jun;88(6):554-569
pubmed: 32105092
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13290-5
pubmed: 9789081
Int J Neuropsychopharmacol. 2014 Oct 31;18(1):
pubmed: 25550331
Am J Psychiatry. 2008 Jun;165(6):740-8
pubmed: 18346998
J Cereb Blood Flow Metab. 2015 Mar 31;35(4):583-91
pubmed: 25564232
Transl Psychiatry. 2015 Feb 24;5:e516
pubmed: 25710122
Neuroscientist. 2013 Feb;19(1):43-61
pubmed: 22547530
Sci Rep. 2020 Feb 12;10(1):2404
pubmed: 32051490
Depress Anxiety. 2019 May;36(5):433-441
pubmed: 30900329
Neuroimage. 2010 Jul 1;51(3):1275-81
pubmed: 20302946
Am J Psychiatry. 2017 Jul 1;174(7):667-675
pubmed: 28135845
J Affect Disord. 2017 Jun;215:213-217
pubmed: 28340447
Suicide Life Threat Behav. 2019 Feb;49(1):23-40
pubmed: 28972271
Neuroimage. 2013 Oct 15;80:246-62
pubmed: 23631983
Psychol Med. 2020 Oct;50(14):2324-2334
pubmed: 31597581
Am J Psychiatry. 2005 Feb;162(2):304-10
pubmed: 15677595
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:222-227
pubmed: 28445688
Transl Psychiatry. 2018 Jun 19;8(1):120
pubmed: 29921964
Sci Rep. 2017 Sep 14;7(1):11637
pubmed: 28912439
J Neurosci. 2009 Feb 11;29(6):1860-73
pubmed: 19211893
Transl Psychiatry. 2019 Jan 17;9(1):17
pubmed: 30655506
Psychol Med. 2016 Apr;46(5):933-44
pubmed: 26670261
Cereb Cortex. 2010 Nov;20(11):2636-46
pubmed: 20154013
Psychol Med. 2016 Jan;46(2):381-91
pubmed: 26446615
Mol Psychiatry. 2017 Aug;22(8):1149-1154
pubmed: 27956745
Psychiatry Res Neuroimaging. 2016 Oct 30;256:50-56
pubmed: 27685801
Annu Rev Clin Psychol. 2016;12:307-30
pubmed: 26772209
Psychol Bull. 2017 Feb;143(2):187-232
pubmed: 27841450
Neurosci Lett. 2013 Feb 8;534:35-40
pubmed: 23201633
Cereb Cortex. 2002 Apr;12(4):386-94
pubmed: 11884354
J Psychiatr Res. 2012 Nov;46(11):1449-55
pubmed: 22868048
Neuroimage. 2007 Oct 1;37(4):1100-11
pubmed: 17681797
J Affect Disord. 2018 Jan 15;226:92-99
pubmed: 28968564
Suicide Life Threat Behav. 2007 Jun;37(3):264-77
pubmed: 17579539
J Affect Disord. 2017 Mar 01;210:303-311
pubmed: 28068619
Sci Rep. 2017 Dec;7(1):89
pubmed: 28273888
J Affect Disord. 2017 Apr 01;212:78-85
pubmed: 28157550
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7900-5
pubmed: 27357684
Cereb Cortex. 2019 May 1;29(5):1984-1996
pubmed: 29668865
Sci Rep. 2019 Oct 4;9(1):14330
pubmed: 31586117
Psychol Med. 2019 Apr;49(5):852-860
pubmed: 29909788
J Clin Psychiatry. 2018 Jul 10;79(4):
pubmed: 29995357
J Clin Psychiatry. 2015 Dec;76(12):1683-6
pubmed: 26717528
Front Hum Neurosci. 2016 Dec 05;10:617
pubmed: 27994546
J Psychiatr Res. 2015 Sep;68:192-7
pubmed: 26228419
Eur J Neurosci. 2010 Aug;32(3):383-98
pubmed: 20662902
Neurosci Biobehav Rev. 2014 Sep;45:100-18
pubmed: 24875392
Biol Psychiatry. 1999 May 1;45(9):1085-98
pubmed: 10331101
Mol Psychiatry. 2020 Feb;25(2):408-427
pubmed: 31787757
BMC Psychiatry. 2016 Sep 29;16(1):337
pubmed: 27688124
J Affect Disord. 2016 Nov 15;205:252-263
pubmed: 27467529
Psychol Med. 2014 Jun;44(8):1663-73
pubmed: 24016405
Sci Rep. 2017 Nov 17;7(1):15772
pubmed: 29150619
Can J Psychiatry. 2012 Apr;57(4):254-62
pubmed: 22480591
Mol Psychiatry. 2010 Aug;15(8):868-76
pubmed: 19337207
Brain. 2014 Aug;137(Pt 8):2382-95
pubmed: 25057133
Trends Cogn Sci. 2013 Dec;17(12):683-96
pubmed: 24231140
Hum Brain Mapp. 2014 Oct;35(10):4979-88
pubmed: 24740815
J Affect Disord. 2018 Aug 15;236:266-273
pubmed: 29751242
World J Biol Psychiatry. 2011 Aug;12(5):319-39
pubmed: 21385016
Epilepsy Behav. 2020 Feb;103(Pt A):106858
pubmed: 31899164
J Affect Disord. 2012 Feb;136(3):398-404
pubmed: 22154567

Auteurs

Gerd Wagner (G)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany. wagner.gerd@uni-jena.de.

Meng Li (M)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.

Matthew D Sacchet (MD)

Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.

Stéphane Richard-Devantoy (S)

McGill group for Suicide Studies, McGill University & Douglas Mental Health University Institute, Montréal, QC, Canada.

Gustavo Turecki (G)

McGill group for Suicide Studies, McGill University & Douglas Mental Health University Institute, Montréal, QC, Canada.

Karl-Jürgen Bär (KJ)

Department of Gerontopsychiatry and Psychosomatics, Jena University Hospital, Jena, Germany.

Ian H Gotlib (IH)

Department of Psychology, Stanford University, Stanford, CA, USA.

Martin Walter (M)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, 07743, Jena, Germany.

Fabrice Jollant (F)

McGill group for Suicide Studies, McGill University & Douglas Mental Health University Institute, Montréal, QC, Canada.
Université de Paris, Faculté de médecine, Paris, France.
GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.
Psychiatry Department, CHU Nîmes, Nîmes, France.
Equipe Moods, INSERM, UMR-1178, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH